Header Logo

Connection

REZA JOHN MEHRAN to Cisplatin

Back to Details
This is a "connection" page, showing publications REZA JOHN MEHRAN has written about Cisplatin.
REZA JOHN MEHRAN
Connection Strength
0.054
Cisplatin
  1. A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer. Clin Cancer Res. 2020 07 15; 26(14):3525-3536.
    View in: PubMed
    Score: 0.026
  2. A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma. Clin Cancer Res. 2017 Dec 15; 23(24):7483-7489.
    View in: PubMed
    Score: 0.022
  3. Neoadjuvant chemotherapy before surgery for resectable carcinoma of the lower esophagus. Dis Esophagus. 1999; 12(2):144-8.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.